News

Amid competition in the cruise line industry, investors seem to have overlooked Royal Caribbean (NYSE: RCL). The larger market share of Carnival and the relatively recent IPO of Viking Holdings seem

How does getting paid to own a stock sound to you? That's exactly what dividends do. Even if you don't need extra income, reinvesting dividends can significantly increase the total returns you

The old saying that "birds of a feather flock together" doesn't always apply to the world of the super-wealthy. Rich investors often follow their own paths rather than buying the same assets. So

Shares in Viking Therapeutics (NASDAQ: VKTX) crashed by 35.9% in the week to Friday morning. The decline comes in a week when the company released its top-line results from its phase 2 trial of its

I happily own stock in Medtronic (NYSE: MDT), one of the largest medical device makers in the world. Of late, the company is struggling through a rough patch that has Wall Street worried about the

Nvidia (NASDAQ: NVDA) closed down 0.2% at $174.98 on Thursday, with trading volume of 135 million shares, below its three-month average of 181 million. The modest decline contrasted with weakness in

The use of robotics in surgery is on the rise. The market was valued at $800 million in 2015, and has since risen to over $3 billion. One reason behind this rapid growth is that these robot systems

As of Aug. 20, shares of Viking Therapeutics (NASDAQ: VKTX) fell a whopping 39.2% from their previous close on Tuesday, Aug. 19. Investors were reacting to new clinical trial results regarding its

Dividend Champions are known for their reliability. These companies have raised their dividends annually for at least 25 years. Some remain overlooked by investors because they don't need to be in

A clutch of post-earnings price target increases by analysts helped raise Medtronic's (NYSE: MDT) stock at a healthy rate on Wednesday. The sturdy medical device specialist's shares rose by almost

Premier (NASDAQ:PINC), a leading provider of healthcare supply chain and performance improvement solutions, reported its fiscal fourth-quarter results on August 20, 2025, for the period ended June

Shares of Viking Therapeutics (NASDAQ: VKTX) rose by almost 10% at 11 a.m. ET today. This follows a significant fall the previous day on the release of its eagerly awaited top-line results from a

Image source: The Motley Fool.

Wednesday, August 20, 2025 at 10 a.m. ET

Chairman, President, and Chief Executive Officer — Vincent Roche

Continue reading

Source Fool.com

The average healthcare stock has a yield of just 1.8%, which isn't much to write home about today. You can do much better than that with Medtronic (NYSE: MDT), currently yielding 3%, or if you're

What's better than a stock that pays great dividends? How about one that's also a bargain? Granted, most strong dividend stocks aren't available at a discount in the current high-flying market

Vertex Pharmaceuticals (NASDAQ: VRTX) has been a top pharma stock in recent years. It has been generating strong revenue growth while also building out its portfolio of drugs, expanding its growth

Shares of health insurer UnitedHealth Group (NYSE: UNH) received a boost last week after investors learned that Warren Buffett's company, Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B), has invested

What the stock analysis community giveth, it can also taketh away.

That was the dynamic behind the slide of UnitedHealth Group (NYSE: UNH) stock on Tuesday. As in the previous trading session, the

Nvidia (NASDAQ: NVDA) shares fell 3.5% on Tuesday, closing at $175.64, as tech stocks broadly pulled back following a recent rally. The chipmaker traded 183 million shares, just above its

Medtronic (NYSE: MDT) stock had declined 3.6% through 2:45 p.m. ET Tuesday despite beating forecasts for fiscal 2026 first-quarter earnings this morning.

Heading into the report, analysts predicted

Viking Therapeutics (NASDAQ: VKTX) stock collapsed in morning trading Tuesday, down more than 40% after reporting mixed results for its GLP-1 weight loss pill VK2735. As Viking shares plummet

Viking Therapeutics (NASDAQ: VKTX) stock collapsed on Tuesday, down 41.4% through 10:25 a.m. ET after reporting what pharmaceutical analysts are calling "mixed results" for its new GLP-1 weight loss

Viking Holdings(NYSE:VIK) reported second-quarter 2025 earnings on August 19, 2025, achieving 18.5% year-over-year revenue growth to $1.9 billion, an adjusted EBITDA increase of 28.5% to $633

Premier(NASDAQ:PINC) reported fourth quarter and full-year 2025 results on August 19, 2025, with revenue of $986 million and adjusted EPS of $1.54, both exceeding guidance. The company’s Supply

Medtronic (NYSE:MDT), a global medical technology leader specializing in cardiovascular, neuroscience, and surgical devices, reported Q1 FY2026 earnings on August 19, 2025. The most notable news